Jul. 2 at 9:29 AM
$ADCT
ADC THERAPEUTICS SA
27,726,052 Common Shares
Pursuant to this prospectus, the selling shareholders may offer an aggregate of 27,726,052 common shares from time to time if and to the extent as they may determine as described in the section entitled “Plan of Distribution” at prevailing market prices, at prices different than prevailing market prices or at privately negotiated prices. If any common shares are sold, the selling shareholders will pay any brokerage commissions and/or similar charges incurred for the sale of such shares.
As required by the securities purchase agreements, dated June 11, 2025, with the selling shareholders, we are filing the registration statement of which this prospectus forms a part to permit the resale of 11,991,785 common shares and 15,734,267 common shares issuable upon exercise of the pre-funded warrants, in each case, issued and sold to the selling shareholders pursuant to such securities purchase agreements. We do not know whether,